Pharma company ranking based on market influence in developing countries 2018

This statistic depicts the pharmaceutical company ranking based on public policy and market influence in developing countries in 2018, according to the Access to Medicine Index. In that year, the company with the highest score in public policy and market influence in these countries was GlaxoSmithKline, scoring 4.01 points. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.

Pharmaceutical company ranking based on market influence and compliance in developing countries in 2018*

Indicator score from 1 (lowest) to 5 (highest)
GlaxoSmithKline plc4.01
Merck KGaA3.34
Novartis AG3.34
Eisai Co. Ltd.3.19
Roche Holding Ltd.3.11
Sanofi3.05
Novo Nordisk A/S3.03
Takeda Pharamceutical Co.3.03
Bristol-Myers Squibb Co.2.71
Pfizer Inc.2.69
Johnson & Johnson2.68
Bayer AG2.61
Merck & Co. Inc.2.6
Astellas Pharma Inc.2.49
AstraZeneca plc2.36
Boehringer-Ingelheim GmbH2.34
Eli Lilly & Co.2.06
Gilead Sciences Inc.1.98
AbbVie Inc.1.59
Daiichi Sankyo Co. Ltd.1.55
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

November 2018

Region

Worldwide

Survey time period

2018

Supplementary notes

* The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
The Index uses a framework that evaluates company activities in seven areas of activity, or technical areas, considered to be key to enhancing access to medicine in developing countries, and across four important aspects of action, or strategic pillars.
A score of zero means lowest and five signifies highest indicator score among the company set.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Monsanto-Bayer"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.